Evidence map›Paper›PMID 39482615›Full record

ArticleBMC cancer2024

Elevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells.

Soraya Sester, Gerrit Wilms, Joana Ahlburg, Aaron Babendreyer, Walter Becker

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soraya SesterInstitute of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany.
Gerrit WilmsInstitute of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany.
Joana AhlburgInstitute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany.
Aaron BabendreyerInstitute of Molecular Pharmacology, RWTH Aachen University, Aachen, Germany.
Walter BeckerInstitute of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany. wbecker@ukaachen.de.ORCID https://orcid.org/0000-0002-0347-4768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe protein kinase DYRK1B is a negative regulator of cell proliferation but has been found to be overexpressed in diverse human solid cancers. While DYRK1B is recognized to promote cell survival and adaption to stressful conditions, the consequences of elevated DYRK1B levels in cancer cells are largely uncharted.

methodsTo elucidate the role of DYRK1B in cancer cells, we established a A549 lung adenocarcinoma cell model featuring conditional overexpression of DYRK1B. This system was used to characterize the impact of heightened DYRK1B levels on gene expression and to monitor phenotypic and functional changes.

resultsA549 cells with induced overexpression of wild type DYRK1B acquired a mesenchymal cell morphology with diminished cell-cell contacts and a reorganization of the pericellular actin cytoskeleton into stress fibers. This transition was not observed in cells overexpressing a catalytically impaired DYRK1B variant. The phenotypic changes were associated with increased expression of the transcription factors SNAIL and SLUG, which are core regulators of epithelial mesenchymal transition (EMT). Further profiling of DYRK1B-overexpressing cells revealed transcriptional changes that are characteristic for the mesenchymal conversion of epithelial cells, including the upregulation of genes that are related to cancer cell invasion and metastasis. Functionally, DYRK1B overexpression enhanced the migratory capacity of A549 cells in a wound healing assay.

conclusionsThe present data identify DYRK1B as a regulator of phenotypic plasticity in A549 cells. Increased expression of DYRK1B induces mesenchymal traits in A549 lung adenocarcinoma cells.

Indexed as

Dyrk KinasesEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticLung NeoplasmsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesA549 CellsAdenocarcinomaAdenocarcinoma of LungCell Line, TumorCell MovementCell ProliferationHumansSnail Family Transcription FactorsDyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSnail Family Transcription FactorsA549Cancer cell migrationDYRK1BLung adenocarcinomaPhenotypic plasticityProtein kinaseStress fibers

Identifiers

PMID39482615
PMCPMC11529244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.